T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBCH
2151
Turtle Beach Corp
TBCH
$230M
| $639K | ﹤0.01% |
41,612
+162
| +0.4% | +$2.36K |
|
2152
Oxford Industries
OXM
$542M
| $638K | ﹤0.01% |
7,350
-18
| -0.2% | -$1.66K |
|
|
TRTX
2153
TPG RE Finance Trust
TRTX
$616M
| $638K | ﹤0.01% |
74,709
+1,497
| +2% | +$13.1K |
|
|
ARR
2154
Armour Residential REIT
ARR
$2.37B
| $637K | ﹤0.01% |
31,198
+600
| +2% | +$12.2K |
|
2155
Edgewise Therapeutics
EWTX
$4.69B
| $636K | ﹤0.01% |
23,808
+722
| +3% | +$14.4K |
|
2156
Core Laboratories
CLB
$569M
| $633K | ﹤0.01% |
34,154
+152
| +0.4% | +$3.05K |
|
2157
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.33B
| $632K | ﹤0.01% |
19,005
+2
| +0% | +$64 |
|
2158
Vishay Precision Group
VPG
$908M
| $630K | ﹤0.01% |
24,320
+3,960
| +19% | +$113K |
|
2159
West Bancorporation
WTBA
$511M
| $630K | ﹤0.01% |
33,123
-3,770
| -10% | -$72.3K |
|
2160
Koppers
KOP
$874M
| $628K | ﹤0.01% |
17,168
+1,187
| +7% | +$44.3K |
|
2161
LendingTree
TREE
$461M
| $623K | ﹤0.01% |
10,719
+103
| +1% | +$5.32K |
|
2162
NETGEAR
NTGR
$647M
| $619K | ﹤0.01% |
30,827
+600
| +2% | +$9.92K |
|
2163
Brookfield Asset Management
BAM
$89.2B
| $616K | ﹤0.01% |
13,028
-12
| -0.1% | -$503 |
|
2164
Xperi
XPER
$320M
| $616K | ﹤0.01% |
66,609
-2,557
| -4% | -$21K |
|
|
DHC
2165
Diversified Healthcare Trust
DHC
$2.03B
| $615K | ﹤0.01% |
146,598
| – | – |
|
2166
Community Health Systems
CYH
$419M
| $612K | ﹤0.01% |
100,687
+1,491
| +2% | +$7.31K |
|
2167
Heritage Financial
HFWA
$1.23B
| $610K | ﹤0.01% |
27,987
-2,719
| -9% | -$58K |
|
2168
BJ's Restaurants
BJRI
$1.42B
| $609K | ﹤0.01% |
18,690
+151
| +0.8% | +$4.87K |
|
2169
Energy Recovery
ERII
$399M
| $608K | ﹤0.01% |
34,911
+783
| +2% | +$12.4K |
|
|
WSR
2170
DELISTED
Whitestone REIT
WSR
| $607K | ﹤0.01% |
44,812
+553
| +1% | +$7.42K |
|
2171
Park Aerospace
PKE
$811M
| $604K | ﹤0.01% |
46,332
+50
| +0.1% | +$663 |
|
2172
Conduent
CNDT
$252M
| $598K | ﹤0.01% |
148,380
+2,000
| +1% | +$7.34K |
|
2173
Hain Celestial
HAIN
$53.9M
| $598K | ﹤0.01% |
69,180
+1,080
| +2% | +$8.09K |
|
2174
Harmony Biosciences
HRMY
$2.24B
| $596K | ﹤0.01% |
14,877
+185
| +1% | +$6.5K |
|
|
HSII
2175
DELISTED
Heidrick & Struggles
HSII
| $596K | ﹤0.01% |
15,330
-2,020
| -12% | -$73K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.